Lochlan Halloway serves as the Senior Equity Strategist at Morningstar Australia. In this role, he is the lead author of the firm's quarterly Australian Market Outlook and acts as the spokesperson for Morningstar's Australian equity research in the media. He also conducts fundamental analysis on ASX-listed healthcare stocks, including CSL, Cochlear, Resmed, and Fisher & Paykel Healthcare.